SlideShare a Scribd company logo
1 of 25
Download to read offline
Copyright © 2015
Jian Wang, PhD
CEO
Next Generation Biobanking
Webinar recording:
https://youtu.be/wvsyL9PUZRg
Copyright © 2015
Copyright © 2015
Biobanking Used to be Simple…
Copyright © 2015
Copyright © 2015
HIGH QUALITY
HIGHLY ANNOTATED
CONSENTED
PATIENT LINKED
SAMPLE
Copyright © 2015
The Critical Biobanking Challenges
Biobanks
Expectation of
driving the
science
Externalization
&
Collaboration
Increased
regulatory
scrutiny
Copyright © 2015
Data Management
& Exploration
Operational
Biobanking
Virtual
Biobanking;
Clinical Trial
Sample /
Consent
Tracking
Copyright © 2015
Sponsor
Clinical Trial Sample
/ Consent Tracking
Site
Central Lab
Site
Site
Testing Lab
Testing Lab
StorageTesting Lab
Copyright © 2015
Site Sponsor
Vendor/ CRO
Sample
Shipment
Consent Deviation /
Sample Destruction
(e.g. patient withdraw)
Sample
Destruction
(patient withdraw
or sponsor policy)
Patient Consent
Trial Setup &
Sample Logistics
Sample Collection
Specification
Sample
Inventory
Consent
Reconciliation
consent
patients &
acquire samples
Sample Tracking Use Case
Sample
Shipment
Copyright © 2015
Support Virtual Biobank
Copyright © 2015
Conceptual Framework
Plan
Reality Consent
Analysis request
Destruction workflow
Operational reporting
Sample/consent reconciliation
…
Copyright © 2015
https://image-store.slidesharecdn.com/2eb15037-d07b-4f31-b93d-043a157b5814-original.jpeg
Copyright © 2015
Typical Process
• Study Planning
• Patients, visits, consents, …
• Sample collection, routing, …
• Patient Enrollment
• Actual patients
• “Expected” samples for patients
• Patient Consent
• Consent on samples
• Consent reconciliation
• Sample Intake
• Receive samples
• Store samples
Copyright © 2015
Typical Process
• Sample Reconciliation
• Reconciliation per study plan
• Data harmonization across all players in the ecosystem
• Sample Request
• Request samples for research use
• With proper approval processes
• Request Fulfillment
• Actually fulfill the sample request
• Potentially across multiple facilities
• Sample Destruction
• End of life, Consent withdraw, …
Copyright © 2015
Example Data Sources
•Study Protocol& Lab Manual: Sample collection/routingplans
•Informed Consent Document: Consent parameters
•IxRS: Subject Info, SID
•EDC: Visit, Subject Consent
•Central Lab (or site): First data on samples, derivative samples,
shipment/receiving,patient info
•Testing lab: derivative samples, shipment/receiving
•Storage: derivative samples, shipment/receiving,future use
Copyright © 2015
Operational Biobank
Copyright © 2015
Research BioBank 1B
PathologySample A597
(text-onlylabel)
Sample Inventory & Operations
Copyright © 2015
Platform Advantage
Operational
• Biobanking workflows
• Access Controls
• Annotations
• More…
Decision Support
• Scientificinsights
• Ad hoc query
• Hypotheses
• Reporting
Uniqueout-of-the boxintegration of the operational with decision
support
Copyright © 2015
ExplorationAcquisition AnalysisAnalysis
Data Harmonization, Reporting & Exploration
Copyright © 2015
Qiagram Enables Data Exploration
Data Managers
Query datadirectly
by themselves
Researchers
SELECT DISTINCT PATIENT_ID, SAMPLE_ID,
SAMPLE_NAME
FROM SAMPLE_INVENTORY S
INNER JOIN PATIENTS P ON S.PATIENT_ID = P.PATIENT_ID
INNER JOIN DIAGNOSIS D ON S.PATIENT_ID =
D.PATIENT_ID
INNER JOIN MEDICATIONS M ON S.PATIENT_ID =
M.PATIENT_ID
INNER JOIN BIOMARKERS B ON S.PATIENT_ID =
B.PATIENT_ID
WHERE
D.DIAGNOSIS_NAME = ‘LUNG CANCER’ AND
M.MEDICATION_GENERIC_NAME = ‘CETUXIMAB’ AND
B.BIOMARKER_NAME = ‘EGFR’ AND
B.OBSERVATION = 1
ORDER BY PATIENT_ID, SAMPLE_NAME
Both now speak
the same language
Copyright © 2015
Clinical Trial Sample Tracking – Can You
Answer These Questions?
Study-specific reports (on-going studies):
1. Planned sample collection report
2. Actual sample collection report
3. Reconciliation of planned vs. actual sample collection
• What samples are missing (or late) for a given visit?
• Which patients have complete set of samples collected for a
given (set of) visits and sample types?
4. Anticipated upcoming sample collections(based on Subject
enrollment and sample collection plan)
5. Sample allowable use (consent) report
Copyright © 2015
Clinical Trial Sample Tracking – Can You
Answer These Questions?
6. Sample Chain of Custody (CoC) report
• Sample location
• Sample status
• Reconciliation of sample location with routing plan
• Expected vs actual timing of CoC events
7. Study Closeout Report
• Number of samples collected,reconciled: Do we have all the
samples for all the patients in the study?
• Subject participation rate (for optional collections)
Copyright © 2015
Clinical Trial Sample Tracking – Can You
Answer These Questions?
Cross-Study Reports:
1. Sample collection performance metrics
• By Facility across studies
• By Country
• By Study
• By Therapeutic area
2. Sample expiration report (based on consent and other parameters)
Copyright © 2015
Example (Mock) Reconciliation Report
Copyright © 2015
For Further Information
25
Contact:
Jian Wang, Ph.D.
CEO
BioFortis, Inc.
10320 Little Patuxent Parkway, Suite 410
Columbia, MD 21044
jwang@biofortis.com

More Related Content

Viewers also liked

Qiagram
QiagramQiagram
Qiagramjwppz
 
Labmatrix Slides 2011 05
Labmatrix Slides 2011 05Labmatrix Slides 2011 05
Labmatrix Slides 2011 05bhughes26
 
PreClinOmics - ZDSD Diabetic Nephropathy
PreClinOmics - ZDSD Diabetic NephropathyPreClinOmics - ZDSD Diabetic Nephropathy
PreClinOmics - ZDSD Diabetic NephropathyPreClinOmics
 
GH and American Legacy Foundation
GH and American Legacy FoundationGH and American Legacy Foundation
GH and American Legacy FoundationGolin
 
Australia
AustraliaAustralia
Australiay3ehps
 
Lentera News edisi #16 Juli 2015
Lentera News edisi #16 Juli 2015Lentera News edisi #16 Juli 2015
Lentera News edisi #16 Juli 2015Ananta Bangun
 
GH and GSK
GH and GSKGH and GSK
GH and GSKGolin
 
GolinHarris 2013 Al's Day: Day of Service
GolinHarris 2013 Al's Day: Day of ServiceGolinHarris 2013 Al's Day: Day of Service
GolinHarris 2013 Al's Day: Day of ServiceGolin
 

Viewers also liked (20)

Qiagram
QiagramQiagram
Qiagram
 
Labmatrix
LabmatrixLabmatrix
Labmatrix
 
Labmatrix
LabmatrixLabmatrix
Labmatrix
 
Labmatrix Slides 2011 05
Labmatrix Slides 2011 05Labmatrix Slides 2011 05
Labmatrix Slides 2011 05
 
PreClinOmics - ZDSD Diabetic Nephropathy
PreClinOmics - ZDSD Diabetic NephropathyPreClinOmics - ZDSD Diabetic Nephropathy
PreClinOmics - ZDSD Diabetic Nephropathy
 
Aims Calendar 2013
Aims Calendar 2013Aims Calendar 2013
Aims Calendar 2013
 
GH and American Legacy Foundation
GH and American Legacy FoundationGH and American Legacy Foundation
GH and American Legacy Foundation
 
Australia
AustraliaAustralia
Australia
 
Market 3.0
Market 3.0Market 3.0
Market 3.0
 
Ebi.ferrier.2011 sdep
Ebi.ferrier.2011 sdepEbi.ferrier.2011 sdep
Ebi.ferrier.2011 sdep
 
Lentera News edisi #16 Juli 2015
Lentera News edisi #16 Juli 2015Lentera News edisi #16 Juli 2015
Lentera News edisi #16 Juli 2015
 
Drug's r
Drug's rDrug's r
Drug's r
 
GH and GSK
GH and GSKGH and GSK
GH and GSK
 
TPL Dataflow - VTD12
TPL Dataflow - VTD12TPL Dataflow - VTD12
TPL Dataflow - VTD12
 
Nursing
Nursing Nursing
Nursing
 
Insp Butterfly
Insp ButterflyInsp Butterfly
Insp Butterfly
 
Gramatica resumo
Gramatica resumoGramatica resumo
Gramatica resumo
 
GolinHarris 2013 Al's Day: Day of Service
GolinHarris 2013 Al's Day: Day of ServiceGolinHarris 2013 Al's Day: Day of Service
GolinHarris 2013 Al's Day: Day of Service
 
GLS
GLSGLS
GLS
 
Leiturablog
LeiturablogLeiturablog
Leiturablog
 

Similar to Wang Webinar Nov 2015 - LinkedIn

SITIST 2015 Dev - Turning big data into presicion medicine real life examples
SITIST 2015 Dev - Turning big data into presicion medicine real life examplesSITIST 2015 Dev - Turning big data into presicion medicine real life examples
SITIST 2015 Dev - Turning big data into presicion medicine real life examplessitist
 
A CEO's Keys to Continuous Quality Improvement
A CEO's Keys to Continuous Quality ImprovementA CEO's Keys to Continuous Quality Improvement
A CEO's Keys to Continuous Quality ImprovementHealth Catalyst
 
Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Stanford University
 
Unity and the Future of Clinical Education
Unity and the Future of Clinical EducationUnity and the Future of Clinical Education
Unity and the Future of Clinical EducationCole Sandau
 
Accelerate and Integrate Digital Health Innovation
Accelerate and Integrate Digital Health InnovationAccelerate and Integrate Digital Health Innovation
Accelerate and Integrate Digital Health InnovationJohn Reites
 
Anteo Diagnostics Microcap Presentation October 2013
Anteo Diagnostics Microcap Presentation October 2013Anteo Diagnostics Microcap Presentation October 2013
Anteo Diagnostics Microcap Presentation October 2013Matt Sanderson
 
Sanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedSanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedCarlynSanguine
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Office of Health Economics
 
Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2Stanford University
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialsUlrich Neumann, FRSA
 
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for PharmaOpportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for PharmaJohn Reites
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...TransCelerate
 
UKADC System Partners Meeting
UKADC System Partners MeetingUKADC System Partners Meeting
UKADC System Partners MeetingScott Buckler
 
Melbourne Genomics Health Alliance
Melbourne Genomics Health AllianceMelbourne Genomics Health Alliance
Melbourne Genomics Health AllianceAmazon Web Services
 

Similar to Wang Webinar Nov 2015 - LinkedIn (20)

SITIST 2015 Dev - Turning big data into presicion medicine real life examples
SITIST 2015 Dev - Turning big data into presicion medicine real life examplesSITIST 2015 Dev - Turning big data into presicion medicine real life examples
SITIST 2015 Dev - Turning big data into presicion medicine real life examples
 
A CEO's Keys to Continuous Quality Improvement
A CEO's Keys to Continuous Quality ImprovementA CEO's Keys to Continuous Quality Improvement
A CEO's Keys to Continuous Quality Improvement
 
AWARE - Providin High Value
AWARE - Providin High ValueAWARE - Providin High Value
AWARE - Providin High Value
 
Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014Gammaglobulin I-Corps@NIH 121014
Gammaglobulin I-Corps@NIH 121014
 
BioIT 2015 Data Lake Talk
BioIT 2015 Data Lake TalkBioIT 2015 Data Lake Talk
BioIT 2015 Data Lake Talk
 
Unity and the Future of Clinical Education
Unity and the Future of Clinical EducationUnity and the Future of Clinical Education
Unity and the Future of Clinical Education
 
Cgix 201506
Cgix 201506Cgix 201506
Cgix 201506
 
Accelerate and Integrate Digital Health Innovation
Accelerate and Integrate Digital Health InnovationAccelerate and Integrate Digital Health Innovation
Accelerate and Integrate Digital Health Innovation
 
Hfma 2014
Hfma 2014Hfma 2014
Hfma 2014
 
Anteo Diagnostics Microcap Presentation October 2013
Anteo Diagnostics Microcap Presentation October 2013Anteo Diagnostics Microcap Presentation October 2013
Anteo Diagnostics Microcap Presentation October 2013
 
NCHICA2014PeacockPreso
NCHICA2014PeacockPresoNCHICA2014PeacockPreso
NCHICA2014PeacockPreso
 
Sanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updatedSanguine sales deck_2015_jg_updated
Sanguine sales deck_2015_jg_updated
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
 
In vitro program
In vitro program In vitro program
In vitro program
 
Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2Result care lean launchpad week 1 slides v2
Result care lean launchpad week 1 slides v2
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trials
 
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for PharmaOpportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
 
UKADC System Partners Meeting
UKADC System Partners MeetingUKADC System Partners Meeting
UKADC System Partners Meeting
 
Melbourne Genomics Health Alliance
Melbourne Genomics Health AllianceMelbourne Genomics Health Alliance
Melbourne Genomics Health Alliance
 

Wang Webinar Nov 2015 - LinkedIn

  • 1. Copyright © 2015 Jian Wang, PhD CEO Next Generation Biobanking Webinar recording: https://youtu.be/wvsyL9PUZRg
  • 3. Copyright © 2015 Biobanking Used to be Simple…
  • 5. Copyright © 2015 HIGH QUALITY HIGHLY ANNOTATED CONSENTED PATIENT LINKED SAMPLE
  • 6. Copyright © 2015 The Critical Biobanking Challenges Biobanks Expectation of driving the science Externalization & Collaboration Increased regulatory scrutiny
  • 7. Copyright © 2015 Data Management & Exploration Operational Biobanking Virtual Biobanking; Clinical Trial Sample / Consent Tracking
  • 8. Copyright © 2015 Sponsor Clinical Trial Sample / Consent Tracking Site Central Lab Site Site Testing Lab Testing Lab StorageTesting Lab
  • 9. Copyright © 2015 Site Sponsor Vendor/ CRO Sample Shipment Consent Deviation / Sample Destruction (e.g. patient withdraw) Sample Destruction (patient withdraw or sponsor policy) Patient Consent Trial Setup & Sample Logistics Sample Collection Specification Sample Inventory Consent Reconciliation consent patients & acquire samples Sample Tracking Use Case Sample Shipment
  • 10. Copyright © 2015 Support Virtual Biobank
  • 11. Copyright © 2015 Conceptual Framework Plan Reality Consent Analysis request Destruction workflow Operational reporting Sample/consent reconciliation …
  • 13. Copyright © 2015 Typical Process • Study Planning • Patients, visits, consents, … • Sample collection, routing, … • Patient Enrollment • Actual patients • “Expected” samples for patients • Patient Consent • Consent on samples • Consent reconciliation • Sample Intake • Receive samples • Store samples
  • 14. Copyright © 2015 Typical Process • Sample Reconciliation • Reconciliation per study plan • Data harmonization across all players in the ecosystem • Sample Request • Request samples for research use • With proper approval processes • Request Fulfillment • Actually fulfill the sample request • Potentially across multiple facilities • Sample Destruction • End of life, Consent withdraw, …
  • 15. Copyright © 2015 Example Data Sources •Study Protocol& Lab Manual: Sample collection/routingplans •Informed Consent Document: Consent parameters •IxRS: Subject Info, SID •EDC: Visit, Subject Consent •Central Lab (or site): First data on samples, derivative samples, shipment/receiving,patient info •Testing lab: derivative samples, shipment/receiving •Storage: derivative samples, shipment/receiving,future use
  • 17. Copyright © 2015 Research BioBank 1B PathologySample A597 (text-onlylabel) Sample Inventory & Operations
  • 18. Copyright © 2015 Platform Advantage Operational • Biobanking workflows • Access Controls • Annotations • More… Decision Support • Scientificinsights • Ad hoc query • Hypotheses • Reporting Uniqueout-of-the boxintegration of the operational with decision support
  • 19. Copyright © 2015 ExplorationAcquisition AnalysisAnalysis Data Harmonization, Reporting & Exploration
  • 20. Copyright © 2015 Qiagram Enables Data Exploration Data Managers Query datadirectly by themselves Researchers SELECT DISTINCT PATIENT_ID, SAMPLE_ID, SAMPLE_NAME FROM SAMPLE_INVENTORY S INNER JOIN PATIENTS P ON S.PATIENT_ID = P.PATIENT_ID INNER JOIN DIAGNOSIS D ON S.PATIENT_ID = D.PATIENT_ID INNER JOIN MEDICATIONS M ON S.PATIENT_ID = M.PATIENT_ID INNER JOIN BIOMARKERS B ON S.PATIENT_ID = B.PATIENT_ID WHERE D.DIAGNOSIS_NAME = ‘LUNG CANCER’ AND M.MEDICATION_GENERIC_NAME = ‘CETUXIMAB’ AND B.BIOMARKER_NAME = ‘EGFR’ AND B.OBSERVATION = 1 ORDER BY PATIENT_ID, SAMPLE_NAME Both now speak the same language
  • 21. Copyright © 2015 Clinical Trial Sample Tracking – Can You Answer These Questions? Study-specific reports (on-going studies): 1. Planned sample collection report 2. Actual sample collection report 3. Reconciliation of planned vs. actual sample collection • What samples are missing (or late) for a given visit? • Which patients have complete set of samples collected for a given (set of) visits and sample types? 4. Anticipated upcoming sample collections(based on Subject enrollment and sample collection plan) 5. Sample allowable use (consent) report
  • 22. Copyright © 2015 Clinical Trial Sample Tracking – Can You Answer These Questions? 6. Sample Chain of Custody (CoC) report • Sample location • Sample status • Reconciliation of sample location with routing plan • Expected vs actual timing of CoC events 7. Study Closeout Report • Number of samples collected,reconciled: Do we have all the samples for all the patients in the study? • Subject participation rate (for optional collections)
  • 23. Copyright © 2015 Clinical Trial Sample Tracking – Can You Answer These Questions? Cross-Study Reports: 1. Sample collection performance metrics • By Facility across studies • By Country • By Study • By Therapeutic area 2. Sample expiration report (based on consent and other parameters)
  • 24. Copyright © 2015 Example (Mock) Reconciliation Report
  • 25. Copyright © 2015 For Further Information 25 Contact: Jian Wang, Ph.D. CEO BioFortis, Inc. 10320 Little Patuxent Parkway, Suite 410 Columbia, MD 21044 jwang@biofortis.com